Groupe Bruxelles Lambert’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$62.2M Sell
2,773,667
-6,000,000
-68% -$156M 100% 1
2026
Q1
$240M Hold
8,773,667
100% 1
2025
Q4
$365M Hold
8,773,667
100% 1
2025
Q3
$405M Hold
8,773,667
100% 1
2025
Q2
$464M Hold
8,773,667
100% 1
2025
Q1
$488M Hold
8,773,667
100% 1
2024
Q4
$380M Hold
8,773,667
100% 1
2024
Q3
$450M Hold
8,773,667
100% 1
2024
Q2
$555M Hold
8,773,667
100% 1
2024
Q1
$581M Hold
8,773,667
100% 1
2023
Q4
$862M Buy
+8,773,667
New +$764M 100% 1

Other funds holding CNXC

Groupe Bruxelles Lambert's CNXC Position: Q2 2026 in Review

Groupe Bruxelles Lambert reduced its Concentrix (CNXC) stake by 68% in Q2 2026, selling an estimated $156M and leaving 2,773,667 shares worth $62.2M. The position accounts for 100% of the portfolio, ranked #1.

Groupe Bruxelles Lambert first reported a position in CNXC in Q4 2023 and has held it in 11 quarters since. The position peaked at $862M in Q4 2023. 271 funds tracked by Wall St. Rank hold CNXC as of Q2 2026.

  • Groupe Bruxelles Lambert held 2,773,667 shares of Concentrix worth $62.2M as of Q2 2026.
  • Groupe Bruxelles Lambert sold 6,000,000 Concentrix shares in Q2 2026, an estimated $156M.
  • Concentrix made up 100% of Groupe Bruxelles Lambert's portfolio in Q2 2026, its #1 holding.
  • Groupe Bruxelles Lambert first reported a position in Concentrix in Q4 2023 and has held it in 11 quarters since.
  • Groupe Bruxelles Lambert's Concentrix position peaked at $862M in Q4 2023.
  • 271 funds tracked by Wall St. Rank held Concentrix as of Q2 2026.

Based on Groupe Bruxelles Lambert's 13F filing for Q2 2026, filed 6 Aug 2026.